Xu F, Gu A, Ma Y
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine - Nuclear Medicine, Shanghai, China.
Acta Endocrinol (Buchar). 2020 Jul-Sep;16(3):329-333. doi: 10.4183/aeb.2020.329.
The I activity for treating Graves' disease (GD) is usually determined based on physician's experience.
This study aimed to design an empirical method that was not only personalized and quantitative, but also simple, convenient, and easy to grasp.
The study population comprised patients with GD, selected between May 2013 and May 2016, who received I therapy in the Outpatient Department of Shanghai Ninth People's Hospital. The first-visit patients of physician 1 were placed in the traditional group: the activity of I (mCi) was calculated using the routine formula: [empirical activity (0.07-0.12 mCi/g) × thyroid mass]/[24-h thyroid I uptake]. The first-visit patients of physician 2 were placed in the personalized group. The activity of I (mCi) was calculated in two steps. First, the initial activity was calculated: 0.1 mCi/g × thyroid mass (g), and then a personalized and quantitative calibration table of I activity was used to obtain a final I activity. The cure rate with a single activity of I was recorded 1 year later.
The traditional and personalized groups included 241 and 282 patients, respectively. Interestingly, the personalized group achieved a higher cure rate [86.5% (244/282) 73.4% (177/241), P = 0.000] with a relatively higher I activity for the first treatment [8.7 (7, 3.5-30) mCi 6.7(6, 2.5-30) mCi, P = 0.000] compared with the traditional group, while the incidence rate of permanent hypothyroidism was not significantly different between the two groups (P = 0.175).
The empirical method designed in this study was reliable.
治疗格雷夫斯病(GD)的碘(I)活度通常根据医生经验确定。
本研究旨在设计一种经验方法,该方法不仅个性化且定量,而且简单、方便且易于掌握。
研究对象为2013年5月至2016年5月在上海第九人民医院门诊接受I治疗的GD患者。医生1的初诊患者被纳入传统组:I活度(毫居里)使用常规公式计算:[经验活度(0.07 - 0.12毫居里/克)×甲状腺重量]/[24小时甲状腺I摄取率]。医生2的初诊患者被纳入个性化组。I活度(毫居里)分两步计算。首先,计算初始活度:0.1毫居里/克×甲状腺重量(克),然后使用I活度的个性化定量校准表获得最终I活度。1年后记录单次I活度的治愈率。
传统组和个性化组分别有241例和282例患者。有趣的是,与传统组相比,个性化组的治愈率更高[86.5%(244/282)对73.4%(177/241),P = 0.000],首次治疗时I活度相对较高[8.7(7,3.5 - 30)毫居里对6.7(6,2.5 - 30)毫居里,P = 0.000],而两组永久性甲状腺功能减退的发生率无显著差异(P = 0.175)。
本研究设计的经验方法可靠。